First National Bank of South Miami’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-4
Closed – – 270
2022
Q2
$0 Hold
4
– – ﹤0.01% 302
2022
Q1
$0 Hold
4
– – ﹤0.01% 341
2021
Q4
$0 Hold
4
– – ﹤0.01% 361
2021
Q3
$1K Hold
4
– – ﹤0.01% 333
2021
Q2
$1K Buy
+4
New +$1.21K ﹤0.01% 326
2020
Q3
– Sell
-15
Closed -$4K – 272
2020
Q2
$4K Hold
15
– – ﹤0.01% 258
2020
Q1
$5K Hold
15
– – 0.01% 242
2019
Q4
$4K Hold
15
– – ﹤0.01% 248
2019
Q3
$3K Hold
15
– – ﹤0.01% 264
2019
Q2
$4K Buy
+15
New +$3.46K ﹤0.01% 265

Other funds holding BIIB

First National Bank of South Miami's BIIB Position: Q3 2022 in Review

First National Bank of South Miami sold out of Biogen (BIIB) in Q3 2022, closing a stake of 4 shares.

First National Bank of South Miami first reported a position in BIIB in Q2 2019 and held it in 10 quarters. The position peaked at $5K in Q1 2020. 985 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

  • First National Bank of South Miami reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
  • First National Bank of South Miami sold 4 Biogen shares in Q3 2022.
  • First National Bank of South Miami first reported a position in Biogen in Q2 2019 and held it in 10 quarters.
  • First National Bank of South Miami's Biogen position peaked at $5K in Q1 2020.
  • 985 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on First National Bank of South Miami's 13F filing for Q3 2022, filed 31 Oct 2022.